RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Tough-to-Treat leukemia
Disease control OngoingThis study is testing a drug called blinatumomab in Chinese children whose B-cell acute lymphoblastic leukemia (B-ALL) has come back or hasn't responded to other treatments. The main goal is to see if the drug can put the cancer into remission. Researchers will also closely monit…
Matched conditions: RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New immune cell therapy tested for tough blood cancers in japan
Disease control OngoingThis study is testing an experimental treatment called KTE-X19, a type of CAR T-cell therapy, in Japanese adults whose mantle cell lymphoma or acute lymphoblastic leukemia has returned or not responded to prior treatments. The main goals are to see how well the treatment works an…
Matched conditions: RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Personalized cell therapy trial offers hope for kids with Tough-to-Treat cancers
Disease control OngoingThis study is testing the safety and effectiveness of a personalized cell therapy called KTE-X19 for children and young adults up to age 21. The therapy is for those whose B-cell leukemia or lymphoma has come back or hasn't responded to other treatments. Doctors modify a patient'…
Matched conditions: RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC